Gerry Proehl
Chief Executive Officer at DERMATA THERAPEUTICS, INC.
Net worth: 6 809 $ as of 2024-03-30
Gerry Proehl active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. | Independent Dir/Board Member | 2014-04-03 | - |
| Chairman | 2021-05-31 | - | |
| Director/Board Member | 2014-04-03 | 2021-05-31 | |
| DERMATA THERAPEUTICS, INC. | Chairman | 2021-03-31 | - |
| Chief Executive Officer | 2014-12-07 | - | |
| Founder | 2014-12-07 | - | |
| President | 2014-12-07 | - | |
| Director/Board Member | 2014-12-07 | 2021-03-31 | |
MDRejuvena, Inc.
 MDRejuvena, Inc. Pharmaceuticals: MajorHealth Technology MDRejuvena, Inc. manufactures skin care products. It specializes in providing products that rejuvenate, enhance and maintain skin health for the patients of physicians and skincare professionals worldwide. The company was founded by David F. Hale in 2013 and is headquartered in Carlsbad, CA. | Director/Board Member | - | - |
Covella Pharmaceuticals, Inc.
 Covella Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Salix Pharmaceuticals Ltd., Covella Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in Bridgewater, NJ. Covella Pharmaceuticals was acquired by Santarus, Inc., part of Salix Pharmaceuticals Ltd. from January 03, 2014 on September 10, 2010 for $0.65 million. | President | - | - |
| Proehl Investment Ventures LLC | Chief Executive Officer | - | - |
| Chairman | - | - |
Career history of Gerry Proehl
Former positions of Gerry Proehl
| Companies | Position | Start | End |
|---|---|---|---|
| QUALIGEN THERAPEUTICS, INC. | Director/Board Member | 2014-03-31 | 2018-05-31 |
| Independent Dir/Board Member | 2014-03-31 | 2018-05-31 | |
| AUSPEX PHARMACEUTICALS INC | Director/Board Member | 2014-01-07 | 2015-04-30 |
| Independent Dir/Board Member | 2014-01-07 | 2015-04-30 | |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Director/Board Member | 2001-12-31 | 2014-01-01 |
| Chief Executive Officer | 2001-12-31 | 2014-01-01 | |
| Chief Operating Officer | 2000-02-29 | 2001-12-30 | |
| Founder | 1999-03-31 | 2014-01-01 | |
| President | 2000-02-29 | 2014-01-01 | |
| Sales & Marketing | 1999-03-31 | 2000-02-29 | |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Director/Board Member | 2004-04-30 | 2006-08-21 |
| ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | - | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Gerry Proehl
| Rockhurst University | Masters Business Admin |
| Wake Forest University | Graduate Degree |
| State University of New York College at Cortland | Undergraduate Degree |
Statistics
International
| United States | 19 |
| Canada | 2 |
Operational
| Director/Board Member | 11 |
| Independent Dir/Board Member | 4 |
| Chief Executive Officer | 3 |
Sectoral
| Health Technology | 13 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| TENAX THERAPEUTICS, INC. | Health Technology |
| DERMATA THERAPEUTICS, INC. | Health Technology |
| Private companies | 14 |
|---|---|
| HMR Pharma, Inc. | |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Salix Pharmaceuticals Ltd.
 Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
Sophiris Bio, Inc.
 Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA. | Health Technology |
Santarus, Inc.
Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Health Technology |
Ritter Pharmaceuticals, Inc.
 Ritter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA. | Health Technology |
Patara Pharma LLC
 Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Patara Pharma LLC provides biotechnology solutions. It develops biopharmaceutical therapy for the treatment of allergic and inflammatory diseases and conditions that affect orphan patient populations. The company was founded by William Gerhart, Pravin Soni and Ahmet Tutuncu in 2013 and is headquartered in San Diego, CA. | Health Technology |
| Kinetek Sports | |
MDRejuvena, Inc.
MDRejuvena, Inc. Pharmaceuticals: MajorHealth Technology MDRejuvena, Inc. manufactures skin care products. It specializes in providing products that rejuvenate, enhance and maintain skin health for the patients of physicians and skincare professionals worldwide. The company was founded by David F. Hale in 2013 and is headquartered in Carlsbad, CA. | Health Technology |
| Hoechst Marion Roussel, Inc. | |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA. | Health Technology |
Covella Pharmaceuticals, Inc.
Covella Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Salix Pharmaceuticals Ltd., Covella Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in Bridgewater, NJ. Covella Pharmaceuticals was acquired by Santarus, Inc., part of Salix Pharmaceuticals Ltd. from January 03, 2014 on September 10, 2010 for $0.65 million. | Health Technology |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
| Proehl Investment Ventures LLC |
- Stock Market
- Insiders
- Gerry Proehl
- Experience
